Catalyst Pharmaceuticals Reports Fourth Quarter and Full
Catalyst Pharmaceuticals, Inc. (Catalyst) has reported record revenues of $214 million, a 48% increase in annual profits for the first time in more than two decades. Here is what happened to the company's latest results.
Source: globenewswire.comPublished on 2023-03-15
Related news
- Practical guidance on avoiding greenwashing – an Australian response | White & Case LLP
- Primaris REIT Announces Strong Q4 / 22 and Full Year 2022 Results
- Moderna , Inc . ( NASDAQ : MRNA ) Q4 2022 Earnings Call Transcript
- ESG in 2022 and Predictions for 2023 | Skadden , Arps , Slate , Meagher & Flom LLP
- Mission Produce™ Establishes Vertical Integration in South Africa , Partners With ZZ2 , Cap , and Core Fruit
- BOARDWALK REIT PROVIDES 2023 GUIDANCE OF ACCELERATING RENTAL REVENUE AND NET OPERATING INCOME GROWTH AS IT REPORTS STRONG 2022 RESULTS AND AN 8 . 3 % INCREASE TO ITS REGULAR DISTRIBUTION
- Weyerhaeuser Reports Fourth Quarter , Full Year Results
- Dada Nexus Limited ( NASDAQ : DADA ) Q4 2022 Earnings Call Transcript
- SILVERCORP REPORTS Q3 FISCAL 2023 ADJUSTED NET INCOME OF $11 . 8 MILLION , $0 . 07 PER SHARE , AND ISSUES FISCAL 2024 PRODUCTION , CASH COSTS , AND CAPITAL EXPENDITURE GUIDANCE
- W & T Offshore Announces Fourth Quarter and Full Year 2022
- 2022 annual results : Atos delivering on strategic transformation plan
- ATLAS REPORTS FOURTH QUARTER 2022 RESULTS
- Mission Produce™ Establishes Vertical Integration in South
- CoStar Group , Inc . ( NASDAQ : CSGP ) Q4 2022 Earnings Call Transcript
- Rotoplas : Fourth Quarter 2022 Results